Healthcare · Biotechnology · NASDAQ
| Market cap | $13.53B |
|---|---|
| Trailing P/E | — |
| FCF yield | -3.4% |
| Revenue growth (YoY) | +126.3% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
BridgeBio Pharma, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jun 8, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | May 8, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Oct 10, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |